Discriminative Features in Three Autosomal Recessive Cutis Laxa Syndromes: Cutis Laxa Iia, Cutis Laxa Iib, and Geroderma Osteoplastica Publisher Pubmed



Kariminejad A¹ ; Afroozan F¹ ; Bozorgmehr B¹ ; Ghanadan A^{2, 3} ; Akbaroghli S⁴ ; Khorshid HRK⁵ ; Mojahedi F⁶ ; Setoodeh A⁷ ; Loh A⁸ ; Tan YX⁸ ; Escandebeillard N⁸ ; Malfait F⁹ ; Reversade B⁸ ; Gardeitchik T¹⁰ Show All Authors Show Affiliations
Source: International Journal of Molecular Sciences Published:2017

Abstract

Cutis laxa is a heterogeneous condition characterized by redundant, sagging, inelastic, and wrinkled skin. The inherited forms of this disease are rare and can have autosomal dominant, autosomal recessive, or X-linked inheritance. Three of the autosomal recessive cutis laxa syndromes, namely cutis laxa IIA (ARCL2A), cutis laxa IIB (ARCL2B), and geroderma osteodysplastica (GO), have very similar clinical features, complicating accurate diagnosis. Individuals with these conditions often present with cutis laxa, progeroid features, and hyperextensible joints. These conditions also share additional features, such as short stature, hypotonia, and congenital hip dislocation, but the severity and frequency of these findings are variable in each of these cutis laxa syndromes. The characteristic features for ARCL2A are abnormal isoelectric focusing and facial features, including downslanting palpebral fissures and a long philtrum. Rather, the clinical phenotype of ARCL2B includes severe wrinkling of the dorsum of the hands and feet, wormian bones, athetoid movements, lipodystrophy, cataract and corneal clouding, a thin triangular face, and a pinched nose. Normal cognition and osteopenia leading to pathological fractures, maxillary hypoplasia, and oblique furrowing from the outer canthus to the lateral border of the supraorbital ridge are discriminative features for GO. Here we present 10 Iranian patients who were initially diagnosed clinically using the respective features of each cutis laxa syndrome. Each patient’s clinical diagnosis was then confirmed with molecular investigation of the responsible gene. Review of the clinical features from the cases reported from the literature also supports our conclusions. © 2017 by the authors. Licensee MDPI, Basel, Switzerland.